Professor Sarah Lovelock and her team will contribute expertise to a new £50 million Medical Research Council Centre of Research Excellence in Mitochondrial Genome Therapeutics, which will accelerate new therapies development for mitochondrial conditions.
www.manchester.ac.uk/about/news/m...
manchester.ac.uk
New centre for mitochondrial genome therapeutics
Scientists at Manchester will contribute specialist expertise in enzyme engineering and therapeutic oligonucleotides to treat mitochondrial disease.